Home Cart Sign in  
Chemical Structure| 1642839-27-7 Chemical Structure| 1642839-27-7

Structure of GRK5-IN-2
CAS No.: 1642839-27-7

Chemical Structure| 1642839-27-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GRK5-IN-2 is a G protein-coupled receptor kinase 5 (GRK5) inhibitor that can regulate insulin expression and release, holding potential value for research in metabolic diseases.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GRK5-IN-2

CAS No. :1642839-27-7
Formula : C20H20N4O4
M.W : 380.40
SMILES Code : N1=CC=2N=C(C=3OC=CC3)N(C2C=C1NC4=CC(OC)=C(OC)C(OC)=C4)C
MDL No. :MFCD34470578

Safety of GRK5-IN-2

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Description
GRK5-IN-2, a pyridine-based bicyclic compound, acts as a potent inhibitor of G-protein-coupled receptor kinase 5 (GRK5). It modulates the expression and/or release of insulin, making it valuable for research into metabolic diseases[1].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.63mL

0.53mL

0.26mL

13.14mL

2.63mL

1.31mL

26.29mL

5.26mL

2.63mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories